We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Artificial Minitransposon Used to Create Protein Mutation Expression Library

By LabMedica International staff writers
Posted on 20 Feb 2012
An efficient new method for producing mutated-protein expression libraries provides unique benefits for protein structure-function studies and for protein engineering.

The minitransposon was specifically designed and used, by random insertion via the MuA transposase enzyme, to create a gene library for expressing a set of protein mutants that provides distinct protein sequence diversity over existing methods. More...


Libraries expressing multiple mutants of a given protein are particularly useful for studying protein mechanisms and the adaptation of proteins during molecular evolution, as well as for designing proteins (such as biosensors and molecular switches) with novel functions in synthetic biology, including potential drug therapy enzymes.

One type of library in use is made up of "circularly permuted" protein mutants, proteins that have been mutated by connecting the two ends (the N- and C-termini) and later breaking elsewhere, often also having altered part(s) in between.

The new method, called PERMutation Using Transposase Engineering (PERMUTE), for making this type of library was developed by senior undergraduate student Manan Mehta and mentor Jonathan Silberg, assistant professor, at Rice University's Department of Biochemistry and Cell Biology (Houston, TX, USA), with assistance from research technician and coauthor Shirley Liu.

"Creating such a library has traditionally required painstaking processes," said Prof. Silberg. "Existing methods for rearranging the bits of information in a protein are slow and arduous to use," he said. "In addition, they are nonideal because they simultaneously create multiple types of mutations, the desired rearrangements, and undesired deletions of important amino acids.”

Prof. Silberg further explained, "With our method, you only generate mutants with rearranged sequences, and you don't need to be an expert in biomolecular engineering. All you need is the DNA that encodes your gene of interest, the artificial minitransposon we engineered and an enzyme. […] It's a way of making, with great control, all of the diversity of this type of mutation that could exist in a protein."

In this particular study, published online ahead of print on February 7, 2012, in the journal Nucleic Acids Research, a library was created where the enzyme adenylate kinase was mutated. The library of mutant proteins was then mined for variants that retained catalytic functional by introducing them into Escherichia coli bacteria then screening and selecting for adenylate kinase activity. Out of about 220 sequenced mutants (about half of which were active), 15 unique sequence variants were identified.

The work was supported by the National Aeronautics and Space Administration (NASA; USA) and the Robert A. Welch Foundation (The Welch Foundation; Houston, TX, USA).

Related Links:

Rice University



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
New
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
New
Alzheimer's Disease Biomarker Assay
Elecsys Phospho-Tau (217P) Plasma
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: WashU Medicine researchers found that dozens of blood proteins shift during Alzheimer’s treatment and may help monitor the effects of the medication. (Image Credit: Matt Miller/WashU Medicine)

Blood Biomarker Patterns Could Support Monitoring of Anti-Amyloid Treatment

Patients with early-stage Alzheimer’s disease may receive anti-amyloid therapy to clear amyloid protein deposits from the brain. These treatments can slow disease progression, but they do not cure the... Read more

Molecular Diagnostics

view channel
Image: University of Florida scientists Hugh Fan, Ph.D., and John Lednicky, Ph.D., led the development of a cost-effective, accurate handheld device capable of simultaneously testing for seven different mosquito-borne viruses. (Image Credit: UF Health photo by Hannah Clark)

Portable Test Differentiates Seven Mosquito-Borne Viruses at Point of Care

Mosquito-borne viral illnesses can present with overlapping symptoms such as fever, joint pain, fatigue, and rash, making them difficult to distinguish without laboratory testing. In these settings, clinicians... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Each PhAST instrument supports random-access processing of up to four samples simultaneously, delivering a throughput of up to 12 samples per eight-hour shift. (Photo courtesy of PhAST)

FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures

Bloodstream infections require prompt treatment, but antimicrobial susceptibility results often lag behind a positive blood culture. Conventional testing can take another 24 to 48 hours after a culture... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.